Doron Cohen
Chief Financial OfficerMr. Doron Cohen serves as Chief Financial Officer at OnKai Inc. He serves as Chief Financial Officer of Eocene Ltd. (formerly known as Galmed Pharmaceuticals Ltd.) since February 23, 2022. He has experience in the global financial markets, including significant experience on the buy side of life sciences companies. Since 2016, he has served as Chief Executive Officer at Tangram Strategic Ltd., a boutique investment firm offering strategic solutions in economic & financial research, risk and regulation. Before that, between 1992 and 2017, he served as Research Director at Gems Investments Research Ltd., an investment research company. During his tenure there, he provided research to hedge funds and managed three teams of analysts, focusing on investment research, operations research and risk analysis. Prior to that from 1990 to 1992, he served as Director of Public Relations at the World Union of Jewish Students. Mr. Cohen holds a Master of Science degree in management from Boston University and a Bachelor’s degree in philosophy and political science from the University of New South Wales.
Positions
- Company NameEocene Ltd.Stock CodeEOCNPositionChief Financial OfficerColleagues
- ABAllen BaharaffCo-Founder, President, CEO & Chairman
- GNGuy NehemyaCOO & Data Protection Officer
- YSYohai StenzlerChief Accounting Officer
- LHLiat HayardenyChief Scientific Officer
- DSDavid SidranskyLead Independent Director
- APAmir PoshinskiIndependent Director
- SNShmuel NirIndependent Director
- VRVlad RatziuMember of Scientific Advisory Board
